DRL publishes first sustainability report for ’04
Dr Reddy’s Laboratories (DRL) released its first ‘Sustainability Report’ for the financial year 2003 -2004. This is a voluntary initiative and is part of the company’s continuing efforts to establish global benchmarks in corporate governance.

NATCO receives CoS for APIs
NATCO Pharma Limited has received the certification of suitability of Monographs of the European Pharmacopoeia for its active pharmaceutical ingredients (APIs)- Ondansetron Hydrochloride Dihydrate and Sumatriptan Succinate.

US based KGK Synergize ties up with Herbicure for research programme
KGK Synergize Inc (KGK), Ontario based globally renowned CRO has recently announced a new partnership programme with Kolkata’s Herbicure Private Limited in the field of contract research including pre-clinical and clinical studies.

Dr Reddy’s initiates phase I trials of cardio drug in Ireland
Dr Reddy’s Laboratories (DRL) has initiated phase I clinical trials for its cardiovascular drug candidate RUS 3108, a release stated.